Tandem Diabetes Care, Inc. (TNDM)

35,12 +0,15 (+0,41%) In data: 10:32AM EDT. Mercato aperto.

Tandem Diabetes Care, Inc.

12400 High Bluff Drive
San Diego, CA 92130
United States
858 366 6900
https://www.tandemdiabetes.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 2.400

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. John F. Sheridan	President, CEO & Director	988,35k	N/D	1955
Ms. Leigh A. Vosseller	Executive VP, CFO & Treasurer	543,38k	N/D	1974
Ms. Susan M. Morrison	Executive VP & Chief Administrative Officer	538,21k	N/D	1979
Mr. David B. Berger Esq.	Transitional Advisor	543,38k	223,28k	1970
Mr. Brian B. Hansen	Executive Officer	561,74k	N/D	1968
Ms. Elizabeth Anne Gasser	Executive Vice President and Chief Strategy & Product Officer	542,91k	N/D	1976
Mr. Mark Novara	Executive VP & Chief Commercial Officer	169,6k	N/D	1975
Mr. Rick A. Carpenter	Chief Technical Officer	N/D	N/D	1963
Ms. Shannon M. Hansen	Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary	N/D	N/D	1966
Mr. Tom Fox	Chief Human Resources Officer	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Governance aziendale

L'ISS Governance QualityScore di Tandem Diabetes Care, Inc. al 1 aprile 2024 è 3. I criteri di valutazione fondamentali sono revisione: 3; Consiglio di Amministrazione: 2; diritti degli azionisti: 4; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.